nutritional support, antibiotics, and radiologic, endoscopic, or surgical interventions.
Here, we review current evidence regarding the diagnosis and management of necrotizing pancreatitis.
■ PROPER TERMINOLOGY HELPS COLLABORATION
Managing necrotizing pancreatitis requires the combined efforts of internists, gastroenterologists, radiologists, and surgeons. This collaboration is aided by proper terminology. A classifi cation system was devised in Atlanta, GA, in 1992 to facilitate communication and interdisciplinary collaboration. 3 Severe pancreatitis was differentiated from mild by the presence of organ failure or the complications of pseudocyst, necrosis, or abscess.
The original Atlanta classifi cation had several limitations. First, the terminology for fl uid collections was ambiguous and frequently misused. Second, the assessment of clinical severity required either the Ranson score or the Acute Physiology and Chronic Health Evaluation II score, both of which are complex and have other limitations. Finally, advances in imaging and treatment have rendered the original Atlanta nomenclature obsolete.
In 2012, the Acute Pancreatitis Classifi cation Working Group issued a revised Atlanta classifi cation that modernized the terminology pertaining to natural history, severity, imaging features, and complications. It divides the natural course of acute pancreatitis into early and late phases. 4 
Early vs late phase
The early phase is within 1 week of symptom onset. In this phase, the diagnosis and treatment are based on laboratory values and clinical assessment. Clinical severity is classifi ed as mild, moderate, or severe ( Table 1) based on organ dysfunction assessed using the Marshall score. 5 In the early phase, fi ndings on computed tomography (CT) neither correlate with clinical severity nor alter clinical management. 6 Thus, early imaging is not indicated unless there is diagnostic uncertainty, lack of response to appropriate treatment, or sudden deterioration.
Moderate pancreatitis describes patients with pancreatic necrosis with or without transient organ failure (organ dysfunction for ≤ 48 hours).
Severe pancreatitis is defi ned by pancreatic necrosis and persistent organ dysfunction. 4 It may be accompanied by pancreatic and peripancreatic fl uid collections; bacteremia and sepsis can occur in association with infection of necrotic collections.
Interstitial edematous pancreatitis vs necrotizing pancreatitis
The revised Atlanta classifi cation maintains the original classifi cation of acute pancreatitis into 2 main categories: interstitial edematous pancreatitis and necrotizing pancreatitis. Necrosis confers greater risk of morbidity and death in pancreatitis FIGURE 1. Acute edematous interstitial pancreatitis. Contrast-enhanced computed tomography through the pancreatic tail (A) and uncinate process (B) shows mild peripancreatic changes (arrows) that blur the interface between the pancreatic parenchyma and the peripancreatic fat. (Figure 1) is rarely clinically severe (approximately 1% to 3% of cases), and mortality risk correlates with the patient's comorbid medical conditions.
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Interstitial edematous pancreatitis
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Necrotizing pancreatitis is further divided into 3 subtypes based on extent and location of necrosis:
• Parenchymal necrosis alone (5% of cases) • Necrosis of peripancreatic fat alone (20%) • Necrosis of both parenchyma and peripancreatic fat (75%). Peripancreatic involvement is commonly found in the mesentery, peripancreatic and distant retroperitoneum, and lesser sac.
Of the three subtypes, peripancreatic necrosis has the best prognosis. However, all of the subtypes of necrotizing pancreatitis are associated with poorer outcomes than interstitial edematous pancreatitis.
Fluid collections
Fluid collections in acute pancreatitis are classifi ed on the basis of the time course, location, and fl uid or solid components (Figure 2 ). In the fi rst 4 weeks, interstitial edematous pancreatitis is associated with acute pancreatic fl uid collections, and necrotizing pancreatitis is associated with acute necrotic collections.
Acute pancreatic fl uid collections contain exclusively nonsolid components without an infl ammatory wall and are typically found in the peripancreatic fat. These collections often resolve without intervention as the patient recovers. If they persist beyond 4 weeks and develop a nonepithelialized, fi brous wall, they become pseudocysts. Intervention is generally not recommended for pseudocysts unless they are symptomatic.
Acute necrotic collections contain both solid and liquid components and can progress to walled-off pancreatic necrosis (Figure 3) . Both early and late collections may be sterile or infected.
■ ROLE OF IMAGING
Radiographic imaging is not usually necessary to diagnose acute pancreatitis. However, it can be a valuable tool to clarify an ambiguous presentation, determine severity, and identify complications.
The timing and appropriate type of imaging are integral to obtaining useful data. Any imaging obtained in acute pancreatitis to evaluate necrosis should be performed at least 3 to 5 days from the initial symptom onset; if imaging is obtained before 72 hours, necrosis cannot be confi dently excluded. 8 
■ COMPUTED TOMOGRAPHY
CT is the imaging test of choice when evaluating acute pancreatitis. In addition, almost all percutaneous interventions are performed with CT guidance.
The Balthazar score is the most well-known CT severity index. It is calculated based on the degree of infl ammation, acute fl uid collections, and parenchymal necrosis. 9 However, a modifi ed severity index incorporates extrapancreatic complications such as ascites and vascular compromise and was found to more strongly correlate with outcomes than the standard Balthazar score. 
Contrast-enhanced CT is performed in 2 phases:
The pancreatic parenchymal phase The pancreatic parenchymal or late arterial phase is obtained approximately 40 to 45 seconds after the start of the contrast bolus. It is used to detect necrosis in the early phase of acute pancreatitis and to assess the peripancreatic arteries for pseudoaneurysms in the late phase of acute pancreatitis.
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Pancreatic necrosis appears as an area of decreased parenchymal enhancement, either well-defi ned or heterogeneous. The normal pancreatic parenchyma has a postcontrast enhancement pattern similar to that of the spleen. Parenchyma that does not enhance to the same degree is considered necrotic. The severity of necrosis is graded based on the percentage of the pancreas involved (< 30%, 30%-50%, or > 50%), and a higher percentage correlates with a worse outcome. 12, 13 Peripancreatic necrosis is harder to detect, as there is no method to assess fat enhancement as there is with pancreatic parenchymal enhancement. In general, radiologists assume that heterogeneous peripancreatic changes, including areas of fat, fl uid, and soft tissue attenuation, are consistent with peripancreatic necrosis. After 7 to 10 days, if these changes become more homogeneous and confl uent with a more mass-like process, peripancreatic necrosis can be more confi dently identifi ed.
12,13
The portal venous phase The later, portal venous phase of the scan is obtained approximately 70 seconds after the start of the contrast bolus. It is used to detect and characterize fl uid collections and venous complications of the disease.
Drawbacks of CT
A drawback of CT is the need for iodinated intravenous contrast media, which in severely ill patients may precipitate or worsen pre-existing acute kidney injury.
Further, several studies have shown that fi ndings on CT rarely alter the management of patients in the early phase of acute pancreatitis and in fact may be an overuse of medical resources.
14 Unless there are confounding clinical signs or symptoms, CT should be delayed for at least 72 hours. 9, 10, 14, 15 ■ MAGNETIC RESONANCE IMAGING Magnetic resonance imaging (MRI) is not a fi rst-line imaging test in this disease because it is not as available as CT and takes longer to perform-20 to 30 minutes. The patient must be evaluated for candidacy, as it is diffi cult for acutely ill patients to tolerate an examination that takes this long and requires them to hold their breath multiple times.
MRI is an appropriate alternative in patients who are pregnant or who have severe iodinated-contrast allergy. While contrast is necessary to detect pancreatic necrosis with MRI is an alternative to CT in patients who are pregnant or allergic to contrast materials FIGURE 3. Infected walled-off necrosis. Unenhanced computed tomography through the head and body of the pancreas (A) and pelvis (B) 4 months after the onset of symptoms shows walled-off necrosis with gas (arrows).
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CT, MRI can detect necrosis without the need for contrast in patients with acute kidney injury or severe chronic kidney disease. Also, MRI may be better in complicated cases requiring repeated imaging because it does not expose the patient to radiation. On MRI, pancreatic necrosis appears as a heterogeneous area, owing to its liquid and solid components. Liquid components appear hyperintense, and solid components hypointense, on T2 fl uid-weighted imaging. This ability to differentiate the components of a walled-off pancreatic necrosis can be useful in determining whether a collection requires drainage or debridement. MRI is also more sensitive for hemorrhagic complications, best seen on T1 fat-weighted images. 12, 16 Magnetic resonance cholangiopancreatography is an excellent method for ductal evaluation through heavily T2-weighted imaging. It is more sensitive than CT for detecting common bile duct stones and can also detect pancreatic duct strictures or extravasation into fl uid collections. 16 
■ SUPPORTIVE MANAGEMENT OF EARLY NECROTIZING PANCREATITIS
In the early phase of necrotizing pancreatitis, management is supportive with the primary aim of preventing intravascular volume depletion. Aggressive fl uid resuscitation in the fi rst 48 to 72 hours, pain control, and bowel rest are the mainstays of supportive therapy. Intensive care may be necessary if organ failure and hemodynamic instability accompany necrotizing pancreatitis. Prophylactic antibiotic and antifungal therapy to prevent infected necrosis has been controversial. Recent studies of its utility have not yielded supportive results, and the American College of Gastroenterology and the Infectious Diseases Society of America no longer recommend it.
9,17 These medications should not be given unless concomitant cholangitis or extrapancreatic infection is clinically suspected.
Early enteral nutrition is recommended in patients in whom pancreatitis is predicted to be severe and in those not expected to resume oral intake within 5 to 7 days. Enteral nutrition most commonly involves bedside or endoscopic placement of a nasojejunal feeding tube and collaboration with a nutritionist to determine protein-caloric requirements.
Compared with enteral nutrition, total parenteral nutrition is associated with higher rates of infection, multiorgan dysfunction and failure, and death. 18 
■ MANAGING COMPLICATIONS OF PANCREATIC NECROSIS
Necrotizing pancreatitis is a defi ning complication of acute pancreatitis, and its presence alone indicates greater severity. However, superimposed complications may further worsen outcomes.
Infected pancreatic necrosis
Infection occurs in approximately 20% of patients with necrotizing pancreatitis and confers a mortality rate of 20% to 50%. 19 Infected pancreatic necrosis occurs when gut organisms translocate into the nearby necrotic pancreatic and peripancreatic tissue. The most commonly identifi ed organisms include Escherichia coli and Enterococcus species. 20 This complication usually manifests 2 to 4 weeks after symptom onset; earlier onset is uncommon to rare. It should be considered when the systemic infl ammatory response syndrome persists or recurs after 10 days to 2 weeks. Systemic infl ammatory response syndrome is also common in sterile necrotizing pancreatitis and sometimes in interstitial pancreatitis, particularly during the fi rst week. However, its sudden appearance or resurgence, high spiking fevers, or worsening organ failure in the later phase (2-4 weeks) of pancreatitis should heighten suspicion of infected pancreatic necrosis.
Imaging may also help diagnose infection, and the presence of gas within a collection or region of necrosis is highly specifi c. However, the presence of gas is not completely sensitive for infection, as it is seen in only 12% to 22% of infected cases.
Before minimally invasive techniques became available, the diagnosis of infected pancreatic necrosis was confi rmed by percutaneous CT-guided aspiration of the necrotic mass or collection for Gram stain and culture.
Antibiotic therapy is indicated in confi rmed or suspected cases of infected pancreIn the early phase, fl uids, pain control, and bowel rest are the mainstays of supportive therapy Antibiotic therapy may provide a bridge to intervention atic necrosis. Antibiotics with gram-negative coverage and appropriate penetration such as carbapenems, metronidazole, fl uoroquinolones, and selected cephalosporins are most commonly used. Meropenem is the antibiotic of choice at our institution.
CT-guided fi ne-needle aspiration is often done if suspected infected pancreatic necrosis fails to respond to empiric antibiotic therapy.
Debridement or drainage. Generally, the diagnosis or suspicion of infected pancreatic necrosis (suggestive signs are high fever, elevated white blood cell count, and sepsis) warrants an intervention to debride or drain infected pancreatic tissue and control sepsis. 21 While source control is integral to the successful treatment of infected pancreatic necrosis, antibiotic therapy may provide a bridge to intervention for critically ill patients by suppressing bacteremia and subsequent sepsis. A 2013 meta-analysis found that 324 of 409 patients with suspected infected pancreatic necrosis were successfully stabilized with antibiotic treatment. 21, 22 The trend toward conservative management and promising outcomes with antibiotic therapy alone or with minimally invasive techniques has lessened the need for diagnostic CT-guided fi ne-needle aspiration.
Hemorrhage
Spontaneous hemorrhage into pancreatic necrosis is a rare but life-threatening complication. Because CT is almost always performed with contrast enhancement, this complication is rarely identifi ed with imaging. The diagnosis is made by noting a drop in hemoglobin and hematocrit.
Hemorrhage into the retroperitoneum or the peritoneal cavity, or both, can occur when an infl ammatory process erodes into a nearby artery. Luminal gastrointestinal bleeding can occur from gastric varices arising from splenic vein thrombosis and resulting left-sided portal hypertension, or from pseudoaneurysms. These can also bleed into the pancreatic duct (hemosuccus pancreaticus). Pseudoaneurysm is a later complication that occurs when an arterial wall (most commonly the splenic or gastroduodenal artery) is weakened by pancreatic enzymes. 
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Prompt recognition of hemorrhagic events and consultation with an interventional radiologist or surgeon are required to prevent death.
Infl ammation and abdominal compartment syndrome
Infl ammation from necrotizing pancreatitis can cause further complications by blocking nearby structures. Reported complications include jaundice from biliary compression, hydronephrosis from ureteral compression, bowel obstruction, and gastric outlet obstruction.
Abdominal compartment syndrome is an increasingly recognized complication of acute pancreatitis. Abdominal pressure can rise due to a number of factors, including fl uid collections, ascites, ileus, and overly aggressive fl uid resuscitation. 24 Elevated abdominal pressure is associated with complications such as decreased respiratory compliance, increased peak airway pressure, decreased cardiac preload, hypotension, mesenteric and intestinal ischemia, feeding intolerance, and lower-extremity ischemia and thrombosis.
Patients with necrotizing pancreatitis who have abdominal compartment syndrome have a mortality rate 5 times higher than patients without abdominal compartment syndrome. 25 Abdominal pressures should be monitored using a bladder pressure sensor in critically ill or ventilated patients with acute pancreatitis. If the abdominal pressure rises above 20 mm Hg, medical and surgical interventions should be offered in a stepwise fashion to decrease it. Interventions include decompression by nasogastric and rectal tube, sedation or paralysis to relax abdominal wall tension, minimization of intravenous fl uids, percutaneous drainage of ascites, and (rarely) surgical midline or subcostal laparotomy.
■ ROLE OF INTERVENTION
The treatment of necrotizing pancreatitis has changed rapidly, thanks to a growing experience with minimally invasive techniques.
Indications for intervention
Infected pancreatic necrosis is the primary indication for surgical, percutaneous, or endoscopic intervention.
In sterile necrosis, the threshold for interInfl ammation from necrotizing pancreatitis can cause further complications by blocking nearby structures FIGURE 5. Further treatment of infected walled-off necrosis in the patient shown in Figures 3 and 4 . At 10 weeks after symptom onset and 6 weeks after catheter placement, laparoscopic-assisted debridement was done via the catheter sites.
Computed tomography without contrast enhancement shows the results of debridement. Large drains (arrows) were placed after debridement.
vention is less clear, and intervention is often reserved for patients who fail to clinically improve or who have intractable abdominal pain, gastric outlet obstruction, or fi stulating disease.
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In asymptomatic cases, intervention is almost never indicated regardless of the location or size of the necrotic area.
In walled-off pancreatic necrosis, less-invasive and less-morbid interventions such as endoscopic or percutaneous drainage or videoassisted retroperitoneal debridement can be done.
Timing of intervention
In the past, delaying intervention was thought to increase the risk of death. However, multiple studies have found that outcomes are often worse if intervention is done early, likely due to the lack of a fully formed fi brous wall or demarcation of the necrotic area. 27 If the patient remains clinically stable, it is best to delay intervention until at least 4 weeks after the index event to achieve optimal outcomes. Delay can often be achieved by antibiotic treatment to suppress bacteremia and endoscopic or percutaneous drainage of infected collections to control sepsis.
Open surgery
The gold-standard intervention for infected pancreatic necrosis or symptomatic sterile walled-off pancreatic necrosis is open necrosectomy. This involves exploratory laparotomy with blunt debridement of all visible necrotic pancreatic tissue.
Methods to facilitate later evacuation of residual infected fl uid and debris vary widely. Multiple large-caliber drains can be placed to facilitate irrigation and drainage before closure of the abdominal fascia. As infected pancreatic necrosis carries the risk of contaminating the peritoneal cavity, the skin is often left open to heal by secondary intention. An interventional radiologist is frequently enlisted to place, exchange, or downsize drainage catheters.
Infected pancreatic necrosis or symptomatic sterile walled-off pancreatic necrosis often requires more than one operation to achieve satisfactory debridement.
The goals of open necrosectomy are to remove nonviable tissue and infection, preserve viable pancreatic tissue, eliminate fi stulous connections, and minimize damage to local organs and vasculature.
Minimally invasive techniques
Percutaneous drainage guided by CT or ultrasonography is currently the most common intervention for infected pancreatic necrosis. After needle access and aspiration of necrotic material for culture, one or more large drains are placed into the necrotic collections for drainage and irrigation. When possible, left fl ank catheters should be placed 2 to 4 cm apart to provide access for laparoscopically guided debridement (Figure 4) . Often, drains are upsized in subsequent sessions to optimally resolve the collections or to provide access ( Figure 5) .
Percutaneous drainage is not always defi nitive, as surgery is eventually required in half of cases. However, it usually controls sepsis and permits delay in surgical debridement pending further maturation of the collection.
Video-assisted retroperitoneal debridement has been described as a hybrid between endoscopic and open retroperitoneal debridement. 28 This technique requires fi rst placing a percutaneous catheter into the necrotic area through the left fl ank to create a retroperitoneal tract. A 5-cm incision is made and the necrotic space is entered using the drain for guidance. Necrotic tissue is carefully debrided under direct vision using a combination of forceps, irrigation, and suction. A laparoscopic port can also be introduced into the incision when the procedure can no longer be continued under direct vision. 29, 30 Although not all patients are candidates for minimal-access surgery, it remains an evolving surgical option.
Endoscopic transmural debridement is another option for infected pancreatic necrosis and symptomatic walled-off pancreatic necrosis. Depending on the location of the necrotic area, an echoendoscope is passed to either the stomach or duodenum. Guided by endoscopic ultrasonography, a needle is passed into the collection, allowing subsequent fi stula creation and stenting for internal drainage or debridement. In the past, this process required several steps, multiple devices, fl uoroscopic guidance, and considerable time.
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But newer endoscopic lumen-apposing metal stents have been developed that can be placed in a single step without fl uoroscopy. A slimmer endoscope can then be introduced into the necrotic cavity via the stent, and the necrotic debris can be debrided with endoscopic baskets, snares, forceps, and irrigation. 9, 31 Similar to surgical necrosectomy, satisfactory debridement is not often obtained with a single procedure; 2 to 5 endoscopic procedures may be needed to achieve resolution. However, the luminal approach in endoscopic necrosectomy avoids the signifi cant morbidity of major abdominal surgery and the potential for pancreaticocutaneous fi stulae that may occur with drains.
In a randomized trial comparing endoscopic necrosectomy vs surgical necrosectomy (video-assisted retroperitoneal debridement and exploratory laparotomy), 32 endoscopic necrosectomy showed less infl ammatory response than surgical necrosectomy and had a lower risk of new-onset organ failure, bleeding, fi stula formation, and death.
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Selecting the best intervention for the individual patient Given the multiple available techniques, selecting the best intervention for individual patients can be challenging. A team approach with input from a gastroenterologist, surgeon, and interventional radiologist is best when determining which technique would best suit each patient.
Surgical necrosectomy is still the treatment of choice for unstable patients with infected pancreatic necrosis or multiple, inaccessible collections, but current evidence suggests a different approach in stable infected pancreatic necrosis and symptomatic sterile walled-off pancreatic necrosis.
The Dutch Pancreatitis Group 28 randomized 88 patients with infected pancreatic necrosis or symptomatic walled-off pancreatic necrosis to open necrosectomy or a minimally invasive "step-up" approach consisting of up to 2 percutaneous drainage or endoscopic debridement procedures before escalation to video-assisted retroperitoneal debridement. The step-up approach resulted in lower rates of morbidity and death than surgical necrosectomy as fi rst-line treatment. Furthermore, some patients in the step-up group avoided the need for surgery entirely. 30 
■ SUMMING UP
Necrosis signifi cantly increases rates of morbidity and mortality in acute pancreatitis. Hospitalists, general internists, and general surgeons are all on the front lines in identifying severe cases and consulting the appropriate specialists for optimal multidisciplinary care. Selective and appropriate timing of radiologic imaging is key, and a vital tool in the management of necrotizing pancreatitis.
While the primary indication for intervention is infected pancreatic necrosis, additional indications are symptomatic walled-off pancreatic necrosis secondary to intractable abdominal pain, bowel obstruction, and failure to thrive. As a result of improving technology and inpatient care, these patients may present with intractable symptoms in the outpatient setting rather than the inpatient setting. The onus is on the primary care physician to maintain a high level of suspicion and refer these patients to subspecialists as appropriate.
Open surgical necrosectomy remains an important approach for care of infected pancreatic necrosis or patients with intractable symptoms. A step-up approach starting with a minimally invasive procedure and escalating if the initial intervention is unsuccessful is gradually becoming the standard of care. 
